Insider · CIK 0001818430
Anders Utter
Files at BIXT (BIOXYTRAN, INC). First filing -, latest -.
In brief
Anders Utter files SEC Form 4 as director at BIXT (BIOXYTRAN, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Anders Utter has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +38,588 | $0.35 | $14k | 372,580 | Nov 18, 2025 |
| Jan 6, 2025 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +97,535 | $0.32 | $31k | 333,992 | Jan 14, 2025 |
| Oct 25, 2024 | BIXT BIOXYTRAN, INC | AGrant or award preferred | +20,619 | $0.46 | $9,485 | 236,457 | Oct 28, 2024 |
Questions about Anders Utter
Answered from the filings on this page, as of the latest one.
Is Anders Utter buying or selling?
Anders Utter has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Anders Utter's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anders Utter has 0.
Where does Anders Utter file Form 4?
Anders Utter has filed Form 4 at BIXT (BIOXYTRAN, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.